Cargando…

Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure

BACKGROUND: We investigated the clinical significance of derivatives of reactive oxygen metabolites (DROMs), a new marker of reactive oxygen species, in patients with nonischemic heart failure (HF) and compared them among new categories of HF. METHODS AND RESULTS: We recruited 201 consecutively hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishihara, Taiki, Yamamoto, Eiichiro, Sueta, Daisuke, Fujisue, Koichiro, Usuku, Hiroki, Oike, Fumi, Takae, Masafumi, Tabata, Noriaki, Ito, Miwa, Yamanaga, Kenshi, Kanazawa, Hisanori, Arima, Yuichiro, Araki, Satoshi, Takashio, Seiji, Nakamura, Taishi, Suzuki, Satoru, Sakamoto, Kenji, Izumiya, Yasuhiro, Kaikita, Koichi, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174381/
https://www.ncbi.nlm.nih.gov/pubmed/33733816
http://dx.doi.org/10.1161/JAHA.120.016765
_version_ 1783702899145048064
author Nishihara, Taiki
Yamamoto, Eiichiro
Sueta, Daisuke
Fujisue, Koichiro
Usuku, Hiroki
Oike, Fumi
Takae, Masafumi
Tabata, Noriaki
Ito, Miwa
Yamanaga, Kenshi
Kanazawa, Hisanori
Arima, Yuichiro
Araki, Satoshi
Takashio, Seiji
Nakamura, Taishi
Suzuki, Satoru
Sakamoto, Kenji
Izumiya, Yasuhiro
Kaikita, Koichi
Tsujita, Kenichi
author_facet Nishihara, Taiki
Yamamoto, Eiichiro
Sueta, Daisuke
Fujisue, Koichiro
Usuku, Hiroki
Oike, Fumi
Takae, Masafumi
Tabata, Noriaki
Ito, Miwa
Yamanaga, Kenshi
Kanazawa, Hisanori
Arima, Yuichiro
Araki, Satoshi
Takashio, Seiji
Nakamura, Taishi
Suzuki, Satoru
Sakamoto, Kenji
Izumiya, Yasuhiro
Kaikita, Koichi
Tsujita, Kenichi
author_sort Nishihara, Taiki
collection PubMed
description BACKGROUND: We investigated the clinical significance of derivatives of reactive oxygen metabolites (DROMs), a new marker of reactive oxygen species, in patients with nonischemic heart failure (HF) and compared them among new categories of HF. METHODS AND RESULTS: We recruited 201 consecutively hospitalized patients with HF and measured DROM under stable conditions. Then, we divided them according to new categories of HF (HF with reduced ejection fraction [EF], HF with midrangeEF, and HF with preserved EF) without coronary artery disease. In subgroup analysis, we followed EF changes in patients with HF with reduced EF and classified them into HF with recovered EF or nonrecovered EF according to whether EF had improved to >40%. DROMs are significantly and independently associated with HF‐related events in patients with NIHF. There were no significant differences in DROM and the probability of HF‐related events among HF categories in Kaplan–Meier analysis. However, patients with HF with reduced EF and HF with preserved EF but not HF with midrange EF with HF‐related events had higher DROM than those without HF‐related events. In subgroup analysis, Kaplan–Meier analysis demonstrated that the probabilities of HF‐related events in HF with recovered EF were dramatically decreased. DROM were significantly higher in patients with HF with nonrecovered EF than in HF with recovered EF. In receiver operating characteristic analysis, the cutoff level of DROM for predicting improvements in HF with recovered EF was 347 Carratelli units. Furthermore, the C‐statistic value for predicting EF improvement for the DROM levels was 0.703. In multivariable logistic regression analysis, DROM was independently and significantly associated with the prediction of HF with recovered EF. CONCLUSIONS: DROM measurements can provide important prognostic information for risk stratification in any category of NIHF. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000035827.
format Online
Article
Text
id pubmed-8174381
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81743812021-06-11 Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure Nishihara, Taiki Yamamoto, Eiichiro Sueta, Daisuke Fujisue, Koichiro Usuku, Hiroki Oike, Fumi Takae, Masafumi Tabata, Noriaki Ito, Miwa Yamanaga, Kenshi Kanazawa, Hisanori Arima, Yuichiro Araki, Satoshi Takashio, Seiji Nakamura, Taishi Suzuki, Satoru Sakamoto, Kenji Izumiya, Yasuhiro Kaikita, Koichi Tsujita, Kenichi J Am Heart Assoc Original Research BACKGROUND: We investigated the clinical significance of derivatives of reactive oxygen metabolites (DROMs), a new marker of reactive oxygen species, in patients with nonischemic heart failure (HF) and compared them among new categories of HF. METHODS AND RESULTS: We recruited 201 consecutively hospitalized patients with HF and measured DROM under stable conditions. Then, we divided them according to new categories of HF (HF with reduced ejection fraction [EF], HF with midrangeEF, and HF with preserved EF) without coronary artery disease. In subgroup analysis, we followed EF changes in patients with HF with reduced EF and classified them into HF with recovered EF or nonrecovered EF according to whether EF had improved to >40%. DROMs are significantly and independently associated with HF‐related events in patients with NIHF. There were no significant differences in DROM and the probability of HF‐related events among HF categories in Kaplan–Meier analysis. However, patients with HF with reduced EF and HF with preserved EF but not HF with midrange EF with HF‐related events had higher DROM than those without HF‐related events. In subgroup analysis, Kaplan–Meier analysis demonstrated that the probabilities of HF‐related events in HF with recovered EF were dramatically decreased. DROM were significantly higher in patients with HF with nonrecovered EF than in HF with recovered EF. In receiver operating characteristic analysis, the cutoff level of DROM for predicting improvements in HF with recovered EF was 347 Carratelli units. Furthermore, the C‐statistic value for predicting EF improvement for the DROM levels was 0.703. In multivariable logistic regression analysis, DROM was independently and significantly associated with the prediction of HF with recovered EF. CONCLUSIONS: DROM measurements can provide important prognostic information for risk stratification in any category of NIHF. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000035827. John Wiley and Sons Inc. 2021-03-18 /pmc/articles/PMC8174381/ /pubmed/33733816 http://dx.doi.org/10.1161/JAHA.120.016765 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Nishihara, Taiki
Yamamoto, Eiichiro
Sueta, Daisuke
Fujisue, Koichiro
Usuku, Hiroki
Oike, Fumi
Takae, Masafumi
Tabata, Noriaki
Ito, Miwa
Yamanaga, Kenshi
Kanazawa, Hisanori
Arima, Yuichiro
Araki, Satoshi
Takashio, Seiji
Nakamura, Taishi
Suzuki, Satoru
Sakamoto, Kenji
Izumiya, Yasuhiro
Kaikita, Koichi
Tsujita, Kenichi
Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title_full Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title_fullStr Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title_full_unstemmed Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title_short Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
title_sort impact of reactive oxidative metabolites among new categories of nonischemic heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174381/
https://www.ncbi.nlm.nih.gov/pubmed/33733816
http://dx.doi.org/10.1161/JAHA.120.016765
work_keys_str_mv AT nishiharataiki impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT yamamotoeiichiro impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT suetadaisuke impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT fujisuekoichiro impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT usukuhiroki impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT oikefumi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT takaemasafumi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT tabatanoriaki impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT itomiwa impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT yamanagakenshi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT kanazawahisanori impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT arimayuichiro impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT arakisatoshi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT takashioseiji impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT nakamurataishi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT suzukisatoru impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT sakamotokenji impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT izumiyayasuhiro impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT kaikitakoichi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure
AT tsujitakenichi impactofreactiveoxidativemetabolitesamongnewcategoriesofnonischemicheartfailure